AI-focused drug discovery firms rise as FDA phases out animal testing

Grandbrothers AI-driven drug discovery firms rallied on Friday after the U.S. Food and Drug Administration (FDA) announced an initiative to reduce or replace animal testing in favor of novel methods, such as computer simulations, to develop antibody therapies and other drugs.

.